Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telotristat Ethyl + PRRT in NETs with Carcinoid Syndrome
NCT04713202Phase 2Withdrawn
- Start
- Mar 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telotristat ethyl in Carcinoid Syndrome (CS), diarrhea. Planned start Mar 2021; status: withdrawn.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Syndrome (CS)diarrhea
Beyond the preview
Go deeper on NCT04713202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04713202.